Form 4 holding
Chief Financial Officer
Eton Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 213,420
- Estimated value
- $3,301,607
- Report date
- 14 Jan 2026
- Price
- $15.47
- Ownership
- Direct
James R. Gruber - Chief Financial Officer at Eton Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- ETON on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by James R. Gruber since 05 Sep 2025
Reported holdings for James R. Gruber in Eton Pharmaceuticals, Inc.
Form 4 holding
Chief Financial Officer
Eton Pharmaceuticals, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 279,931
- Estimated value
- $206,527
- Report date
- 12 Jan 2026
- Price
- $7.98
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
Eton Pharmaceuticals, Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 254,075
- Estimated value
- Report date
- 12 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for James R. Gruber in Eton Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.